Background The decline in postmenopausal serum estrogen concentration results in several
changes in the vulvovaginal and vesicourethral areas, resulting in the genitourinary …

Introduction and hypothesis The aim of this study is to provide an evidence-based definition
of vaginal atrophy (VA) and present an overview of subjective and objective measurements …

Introduction Atrophic vaginitis is a common occurrence, particularly among postmenopausal
women; however, few seek or receive treatment. One therapeutic solution is topically …

Objective: Approximately 50% to 70% of breast cancer survivors are affected by one or more
symptoms of vulvovaginal atrophy (VVA). For those who cannot take hormone therapy …

Glycosaminoglycans (GAGs) are linear, negatively charged polysaccharides composed of
repeating disaccharide units of uronic acid and amino sugars. The luminal surface of the …

Background Most perimenopausal and postmenopausal women experience estrogen
deficiency–induced vaginal atrophy. However, estrogen replacement therapy has …

Background Vaginal dryness (VD) represents a significant concern affecting women across
diverse life stages, encompassing both pre-and postmenopausal women at any age …

Urogenital atrophy occurs as a result of the effect of estrogen deficiency on the tissue quality
in the vulva, vagina, urethra and bladder. It is a common consequence of the menopause …

Objetivo: Identificar las propuestas terapéuticas disponibles para el manejo de la
vulvovaginitis atrófica o atrofia vulvovaginal posmenopáusica (AVVP) o síndrome …

Objetivo: el ácido hialurónico es clave en la hidratación, elasticidad y lubricación vaginal.
Hemos valorado la eficacia de un gel de ácido hialurónico (Hyaluron mucus®) en el …